1 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF ILLINOIS 

EASTERN DIVISION 

--------------------------------------------------------------

JOHNSON & JOHNSON, ETHICON, INC., 

ETHICON US, LLC, and JOHNSON & 

JOHNSON HEALTH CARE SYSTEMS INC., 

Plaintiffs, 

v. 

ADVANCED INVENTORY MANAGEMENT, 

INC. d/b/a ESUTURES.COM, ANTHONY 

IADEROSA JR., JASON EINHORN, MIKE 

PHIPPS, and MUDASSAR SHAH, 

Defendants.

: 

: 

: 

: 

: 

: 

: 

: 

: 

: 

: 

: 

: 

: 

:

Case No. 20-cv-3471 

CONSENT JUDGMENT AND 

PERMANENT INJUNCTION 

---------------------------------------------------------------

On consent of Plaintiffs Johnson & Johnson, Ethicon, Inc., Ethicon US, LLC, and 

Johnson & Johnson Health Care Systems Inc. (collectively “Ethicon”) and Defendants Advanced 

Inventory Management, Inc. d/b/a eSutures.com (“AIM”), Anthony Iaderosa Jr., Jason Einhorn, 

and Mike Phipps (collectively, “eSutures”), it is hereby ORDERED, ADJUDGED, AND 

DECREED: 

WHEREAS, on July 31, 2020, Ethicon filed a First Amended Complaint in Johnson & 

Johnson et al. v. Advanced Inventory Management, Inc. d/b/a eSutures.com et al., No. 1:20-cv3471 (the “Action”) in the United States District Court for the Northern District of Illinois (the 

“Court”), asserting claims for, among other things, federal and state trademark infringement, false 

description and designation of origin in commerce, federal false advertising, federal and state 

trademark dilution and counterfeiting, state deceptive and unfair trade practices, common law 

unfair competition, common law unjust enrichment, common law tortious interference with 

contract, and breach of settlement agreement, all of which claims, Ethicon has alleged, have given 

rise to significant damages; 

WHEREAS, on September 14, 2020, AIM and Phipps filed counterclaims against Ethicon 

in the Action, asserting claims for wrongful seizure, tortious interference with business 

relationships, and trespass to chattels, all of which claims, AIM and Phipps have alleged, have 

given rise to significant damages; 

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 1 of 27 PageID #:27504
2 

NOW THEREFORE: 

1. eSutures, along with its principals, agents, attorneys, members, servants, 

employees, directors, officers, parents, successors, heirs, assigns, executors, representatives, and 

subsidiaries, and all other persons in active concert and participation with them, or who 

otherwise aid and abet eSutures, are permanently enjoined from manufacturing, buying, selling, 

importing, marketing, advertising, distributing, or in any way using in commerce worldwide any 

goods, including authentic goods, manufactured, distributed, marketed or sold by or for Johnson 

& Johnson or its current or future direct or indirect subsidiaries (the “Johnson & Johnson 

Products”). eSutures shall consult Johnson & Johnson’s yearly 10-K filings to determine 

Johnson & Johnson’s direct and indirect subsidiaries. A list of Johnson & Johnson’s direct and 

indirect subsidiaries as of the date of this Consent Judgment and Permanent Injunction is 

attached hereto as Appendix A. Ethicon shall also have the right, but not the obligation, to notify 

eSutures of any new direct or indirect subsidiaries Johnson & Johnson acquires. 

2. If in the future Johnson & Johnson acquires a new direct or indirect 

subsidiary, and eSutures has products in its inventory manufactured, distributed, marketed or 

sold by that subsidiary, then eSutures will have six (6) months from the date of notice provided 

by Ethicon of the acquisition of the subsidiary or from the date of the Johnson & Johnson 10-K 

filing that includes the new subsidiary, whichever is earlier, to sell or otherwise dispose of such 

products. If in the future any current or future direct or indirect subsidiary of Johnson & Johnson 

ceases to be owned by Johnson & Johnson, then eSutures shall no longer be enjoined from 

manufacturing, buying, selling, importing, marketing, advertising, distributing, or in any way 

using in commerce worldwide any goods that were or are at any time manufactured, distributed, 

marketed or sold by that subsidiary regardless of whether trademarks registered to Johnson & 

Johnson continue to appear on such goods, except that eSutures shall not sell any product that 

has on it a trademark that has not been sold and is registered to or owned by Johnson & Johnson 

or any of its remaining subsidiaries. 

3. eSutures, along with its principals, agents, attorneys, members, servants, 

employees, directors, officers, parents, successors, heirs, assigns, executors, representatives, and 

subsidiaries, and all other persons in active concert and participation with them, or who 

otherwise aid and abet eSutures, are further permanently enjoined from mentioning “Ethicon,” 

“Johnson & Johnson,” or any of Johnson & Johnson’s current or future direct or indirect 

subsidiaries, or using any of the Johnson & Johnson Products in its publicity, promotion, or 

advertising including, without limitation, on any domain name, website, uniform resource locator 

(URL), Internet store, or online marketplace platform, including, without limitation, eBay, 

Amazon, and Alibaba. 

4. eSutures, along with its principals, agents, attorneys, members, servants, 

employees, directors, officers, parents, successors, heirs, assigns, executors, representatives, and 

subsidiaries, and all other persons in active concert and participation with them, or who 

otherwise aid and abet eSutures, are further permanently enjoined from using any logo, trade 

name, or trademark which may be calculated to falsely represent or which has the effect of 

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 2 of 27 PageID #:27505
3 

falsely representing that the services or products of eSutures are sponsored by, authorized by, or 

in any way associated with Ethicon, Johnson & Johnson, or any of Johnson & Johnson’s current 

or future direct or indirect subsidiaries, or affixing, applying, annexing, or using in connection 

with the sale of any goods a false description or representation including words or other symbols 

tending to falsely describe or represent such goods as being Ethicon products, or engaging in any 

act which is likely to cause the trade, retailers, or members of the purchasing public to believe 

that eSutures is associated with Ethicon, Johnson & Johnson, or any of Johnson & Johnson’s 

current or future direct or indirect subsidiaries. 

5. Nothing in the preceding paragraphs is intended to enjoin individual 

employees, officers, or principals of eSutures from making personal, non-business purchases and 

use of Johnson & Johnson Products. 

6. If from time to time eSutures accidentally, inadvertently, or otherwise 

comes into possession of Johnson & Johnson Products, then eSutures shall immediately isolate 

the product from the remainder of eSutures’ inventory and shall promptly return the product to 

the person or entity to which it belongs or shall destroy the product but in no case shall eSutures 

sell or redistribute the product. eSutures shall provide a report of all such products and their 

disposition to Ethicon on a quarterly basis. To the extent that following the Seizure Order 

entered in this case any products bearing the Ethicon Marks, as defined at Dkt. No. 31, have 

inadvertently come into eSutures’ possession and have been maintained by eSutures in 

accordance with the Temporary Restraining Order and/or Preliminary Injunction in this case, 

then eSutures shall within fourteen (14) days after entry of this Consent Judgment and Permanent 

Injunction provide them to Ethicon for destruction as set forth in Paragraph 7. 

7. Fourteen days after the entry of this Consent Judgment and Permanent 

Injunction, eSutures shall provide Ethicon with all Johnson & Johnson Products in its possession, 

custody or control. Ethicon shall pick up all such goods at eSutures’s offices and warehouse. 

Ethicon shall destroy such goods at its own expense. Ethicon shall also destroy, at its own 

expense, all of the goods that were seized at eSutures during the execution of the Court’s seizure 

order in June 2020. 

8. Within fourteen days after entry of this Consent Judgment and Permanent 

Injunction, each Party must destroy all Confidential Information (as defined in the 

Confidentiality Order in the Action, Dkt. No. 65 (the “Confidentiality Order”)) and documents 

marked “CONFIDENTIAL – SUBJECT TO PROTECTIVE ORDER” or “ATTORNEYS’ 

EYES ONLY.” For the avoidance of doubt, this paragraph includes but is not limited to all 

records, data, and electronic images obtained during the seizure in this Action in June 2020, and 

Ethicon shall destroy or return to eSutures all electronic and physical records and data in its 

possession that were seized from eSutures and its employees and principals in June 2020, except 

that counsel for Ethicon may retain an archival copy of all court submissions (including 

pleadings and motion papers), transcripts, exhibits, legal memoranda, correspondence, or 

attorney work product. Any retained records will continue to be protected under the 

Confidentiality Order entered in this case. 

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 3 of 27 PageID #:27506
4 

9. Within fourteen days after entry of this Consent Judgment and Permanent 

Injunction, UnitedLex Corp., which the Court appointed as the custodian for records seized from 

eSutures and its employees and principals in June 2020, shall destroy or return to eSutures all 

electronic and physical records and data in its possession that were seized from eSutures and its 

employees and principals in June 2020. 

10. eSutures and its parent companies, subsidiaries, and affiliates shall 

maintain complete records of their purchases and sales of all Johnson and Johnson Products for a 

period of ten years following entry of this Consent Judgment and Permanent Injunction. For a 

period of ten years following entry of this Consent Judgment and Permanent Injunction, Ethicon 

shall have the right, upon at least thirty days prior written notice, to have an independent firm 

audit eSutures’s records of purchases and sales of all products purchased or sold by eSutures 

after the date of this Consent Judgment. Ethicon’s right to such an audit shall not be exercised 

more than once in any twelve-month period. In the event of such an audit, Ethicon shall ensure 

that the independent auditor does not provide any information obtained from the audit to Ethicon 

other than information relating to products purchased or sold by eSutures in violation of this 

Consent Judgment and Permanent Injunction. 

11. eSutures and its principals may not invest in, control, have any direct or 

indirect ownership interest in, work for, lend money to, or participate in any business that 

violates any term of this Consent Judgment or sells, manufactures or distributes Johnson & 

Johnson Products. However, nothing in this order shall prohibit eSutures or its principals from 

owning less than 5% of any corporation whose shares are traded freely on a stock exchange. 

12. If eSutures is found by any court to have violated the prohibitions of this 

Consent Judgment by selling authentic Johnson & Johnson Products, Ethicon is entitled at its 

election to liquidated damages of one hundred times (100x) the list price of the authentic product 

that eSutures sells (or has sold on its behalf by its principals, agents, attorneys, members, 

servants, employees, directors, officers, parents, successors, heirs, assigns, executors, 

representatives, and subsidiaries, and all other persons in active concert and participation with 

them, or who otherwise aid and abet eSutures in violating this Consent Judgment) that violate 

this Consent Judgment; or to Ethicon’s actual, statutory, and punitive damages. Liability of each 

of AIM and Iaderosa will be joint and several among AIM and Iaderosa. 

13. This Consent Judgment is based upon a Settlement Agreement in which 

neither eSutures nor Ethicon makes an admission of liability or wrongdoing. 

14. Ethicon and eSutures each agree that jurisdiction and venue for an action 

for contempt of this Consent Judgment exists in the United States District Court for the Northern 

District of Illinois. In such an action, eSutures shall waive any and all defenses based upon 

personal jurisdiction, subject matter jurisdiction, and venue. 

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 4 of 27 PageID #:27507
5 

15. This Consent Judgment is entered pursuant to Rule 58 of the Federal Rules 

of Civil Procedure, and this Action is hereby dismissed, with prejudice, as to eSutures and as to 

Ethicon, without costs or attorneys’ fees, save that this Court shall retain jurisdiction over this 

action, including, without limitation, over implementation of or disputes arising out of this 

Consent Judgment with regard to eSutures or its principals, agents, attorneys, members, servants, 

employees, directors, officers, parents, successors, heirs, assigns, executors, representatives, and 

subsidiaries. 

16. eSutures relinquishes all rights to the funds identified below (the “Frozen 

Settlement Funds”): 

Bank Name Account Title Account Number 

Ending In 

Amount 

Lakeside Bank AIM 0900 $6,000,000

17. Upon service of this Order on Lakeside bank it shall transfer the Frozen 

Settlement Funds from Advanced Inventory Management account 0900 to a non-interest-bearing 

escrow account held by counsel for Plaintiffs at Citibank, Private Banking Division, 153 East 

53th Street, New York, NY 10022, ABA # 021000089, Swift # CITIUS33, Account # 1288, 

Account Name Patterson Belknap Webb & Tyler LLP Attorney Trust Account-IOLA. 

Confirmation of the date and amount of each wire transfer shall be sent to counsel for Ethicon at 

GPotter@pbwt.com and counsel for eSutures at GMarshall@bradley.com and 

ESullivan@bradley.com. After the Frozen Settlement Funds are transferred Lakeside Bank shall 

immediately unfreeze the account. 

18. The Court’s asset freeze (Dkt. No. 30, as modified by Dkt. Nos. 68, 284, 

290) is hereby DISSOLVED and of no further force and effect. Except as provided for in 

paragraph 17, upon service of this Consent Judgment upon any bank, brokerage house, or 

financial institution holding frozen assets under the asset freeze order, such assets shall be 

immediately unfrozen. Confirmation of the unfreezing of these assets shall be sent to counsel for 

Plaintiffs at GPotter@pbwt.com and counsel for eSutures at GMarshall@bradley.com and 

ESullivan@bradley.com. 

19. Plaintiffs’ October 8, 2020 Atlantic Specialty Insurance Company 

Undertaking on Preliminary Injunction, Bond Number 800-054-586, in the amount of 

$750,000.00, is hereby released. 

20. Signatures to this Consent Judgment transmitted electronically or by 

facsimile shall be deemed original. 

{Signatures on following page} 

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 5 of 27 PageID #:27508
6 

Dated: February __, 2021 

CONSENTED AND AGREED TO BY: 

___________________________________ 

BRADLEY J. ANDREOZZI (ARDC No. 

6286557) 

MATTHEW M. MORRISSEY (ARDC No. 

6302575) 

FAEGRE DRINKER BIDDLE & REATH LLP 

191 North Wacker Drive, Suite 3700 

Chicago, IL 60606-1698 

Tel: (312) 569-1000 

Fax: (312) 569-3000 

bradley.andreozzi@faegredrinker.com

matthew.morrissey@faegredrinker.com

and 

___________________________________ 

GEOFFREY POTTER 

ARON FISCHER (admission application to be 

submitted) 

TIMOTHY A. WATERS (admission 

application to be submitted) 

JOSHUA R. STEIN 

JACQUELINE LASH 

PATTERSON BELKNAP WEBB & TYLER 

LLP 

1133 Avenue of the Americas 

New York, NY 10036-6710 

Tel: (212) 336-2000 

Fax: (212) 336-2222 

gpotter@pbwt.com 

afischer@pbwt.com 

twaters@pbwt.com

jstein@pbwt.com 

jlash@pbwt.com 

Attorneys for Plaintiffs Johnson & Johnson, 

Ethicon, Inc., Ethicon US, LLC, and Johnson 

& Johnson Health Care Systems Inc.

_________________________________ 

Jack Selden 

Greg Marshall 

Scarlett Nokes 

Erin Sullivan 

Michael Denniston 

BRADLEY ARANT BOULT CUMMINGS LLP 

jselden@bradley.com

gmarshall@bradley.com

snokes@bradley.com 

esullivan@bradley.com 

mdenniston@bradley.com

and 

_________________________________ 

Alexander Vesselinovitch 

Matthew T. Connelly 

D. Richard Self 

FREEBORN & PETERS LLP 

avesselinovitch@freeborn.com 

mconnelly@freeborn.com 

rself@freeborn.com

Counsel for Defendants Advanced Inventory 

Management, Inc. d/b/a eSutures.com, 

Anthony Iaderosa Jr., Jason Einhorn, and 

Mike Phipps 

d

_________________________

EOFFREY POTTER

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 6 of 27 PageID #:27509
Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 7 of 27 PageID #:27510
Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 8 of 27 PageID #:27511
7 

Johnson & Johnson 

By: ______________________________ 

Ethicon, Inc. 

By: ______________________________ 

Ethicon US, LLC 

By: ______________________________ 

Johnson & Johnson Health Care Systems Inc. 

By: ______________________________ 

Advanced Inventory Management, Inc. d/b/a 

eSutures.com 

By: ______________________________ 

Anthony Iaderosa Jr. 

By: ______________________________ 

Jason Einhorn 

By: ______________________________ 

Mike Phipps 

By: ______________________________ 

SO ORDERED: 

________________________________ 

UNITED STATES JUDGE 

 Oray B. Boston Jr.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 9 of 27 PageID #:27512
7 

Johnson & Johnson 

By: ______________________________ 

Ethicon, Inc. 

By: ______________________________ 

Ethicon US, LLC 

By: ______________________________ 

Johnson & Johnson Health Care Systems Inc. 

By: ______________________________ 

Advanced Inventory Management, Inc. d/b/a 

eSutures.com 

By: ______________________________ 

Anthony Iaderosa Jr. 

By: ______________________________ 

Jason Einhorn 

By: ______________________________ 

Mike Phipps 

By: ______________________________ 

SO ORDERED: 

________________________________ 

UNITED STATES JUDGE 

Nefertiti 

Greene

Digitally signed by Nefertiti Greene 

DN: c=US, o=JNJ, ou=Subscribers, 

0.9.2342.19200300.100.1.1=1039330, 

cn=Nefertiti Greene 

Reason: I attest to the accuracy and integrity of 

this document. 

Date: 2021.02.02 15:59:11 -05'00' 

Adobe Reader version: 11.0.20

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 10 of 27 PageID #:27513
Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 11 of 27 PageID #:27514
Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 12 of 27 PageID #:27515
Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 13 of 27 PageID #:27516
Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 14 of 27 PageID #:27517
Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 15 of 27 PageID #:27518
Appendix A

3Dintegrated ApS

Acclarent, Inc.

Actelion Ltd

Actelion Manufacturing GmbH

Actelion Pharmaceuticals Australia Pty. Limited

Actelion Pharmaceuticals Korea Ltd.

Actelion Pharmaceuticals Ltd

Actelion Pharmaceuticals Mexico S.A. De C.V.

Actelion Pharmaceuticals Trading (Shanghai) Co., Ltd.

Actelion Pharmaceuticals UK Limited

Actelion Pharmaceuticals US, Inc.

Actelion Registration Limited

Actelion Treasury Unlimited Company

Akros Medical, Inc.

Albany Street LLC

ALZA Corporation

Alza Land Management, Inc.

AMO (Hangzhou) Co., Ltd.

AMO (Shanghai) Medical Devices Trading Co., Ltd.

AMO ASIA LIMITED

AMO Australia Pty Limited

AMO Canada Company

AMO Denmark ApS

AMO Development, LLC

AMO France

AMO Germany GmbH

AMO Groningen B.V.

AMO International Holdings

AMO Ireland

AMO Ireland Finance Unlimited Company

AMO Italy SRL

AMO Japan K.K.

AMO Manufacturing Spain S.L.

AMO Manufacturing USA, LLC

AMO Netherlands BV

AMO Nominee Holdings, LLC

AMO Norway AS

AMO Puerto Rico Manufacturing, Inc.

AMO Sales and Service, Inc.

AMO Singapore Pte. Ltd.

AMO Spain Holdings, LLC

AMO Switzerland GmbH

AMO U.K. Holdings, LLC

AMO United Kingdom, Ltd.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 16 of 27 PageID #:27519
AMO Uppsala AB

AMO US Holdings, Inc.

AMO USA Sales Holdings, Inc.

AMO USA, LLC

Animas Diabetes Care, LLC

Animas LLC

Animas Technologies LLC

AorTx, Inc.

Apsis

Aragon Pharmaceuticals, Inc.

Asia Pacific Holdings, LLC

Atrionix, Inc.

AUB Holdings LLC

Auris Health, Inc.

Backsvalan 2 Aktiebolag

Backsvalan 6 Handelsbolag

Beijing Dabao Cosmetics Co., Ltd.

BeneVir BioPharm, Inc.

Berna Rhein B.V.

BioMedical Enterprises, Inc.

Biosense Webster (Israel) Ltd.

Biosense Webster, Inc.

C Consumer Products Denmark ApS

Calibra Medical LLC

Campus-Foyer Apotheke GmbH

Carlo Erba OTC S.r.l.

Centocor Biologics, LLC

Centocor Research & Development, Inc.

ChromaGenics B.V.

Ci:Labo Customer Marketing Co., Ltd.

Ci:z. Labo Co., Ltd.

Cilag AG

Cilag GmbH International

Cilag Holding AG

Cilag Holding Treasury Unlimited Company

Cilag-Biotech, S.L.

CNA Development GmbH

Codman & Shurtleff, Inc.

Coherex Medical, Inc.

ColBar LifeScience Ltd.

Company Store.com, Inc.

Cordis de Mexico, S.A. de C.V.

Cordis International Corporation

Corimmun GmbH

CoTherix Inc.

CSATS, Inc.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 17 of 27 PageID #:27520
Darlain Trading S.A.

Debs-Vogue Corporation (Proprietary) Limited

DePuy France

DePuy Hellas SA

DePuy International Limited

DePuy Ireland Unlimited Company

DePuy Mexico, S.A. de C.V.

DePuy Mitek, LLC

DePuy Orthopaedics, Inc.

DePuy Products, Inc.

DePuy Spine, LLC

DePuy Synthes Gorgan Limited

DePuy Synthes Institute, LLC

DePuy Synthes Leto SARL

DePuy Synthes Products, Inc.

DePuy Synthes Sales, Inc.

DePuy Synthes, Inc.

Dr. Ci:Labo Co., Ltd.

DR. CI:LABO COMPANY LIMITED

Dutch Holding LLC

ECL7, LLC

EES Holdings de Mexico, S. de R.L. de C.V.

EES, S.A. de C.V.

EIT Emerging Implant Technologies GmbH

Ethicon Biosurgery Ireland

Ethicon Endo-Surgery (Europe) GmbH

Ethicon Endo-Surgery, Inc.

Ethicon Endo-Surgery, LLC

Ethicon Holding Sarl

Ethicon Ireland Unlimited Company

Ethicon LLC

Ethicon PR Holdings Unlimited Company

Ethicon Sarl

Ethicon US, LLC

Ethicon Women's Health & Urology Sarl

Ethicon, Inc.

Ethnor (Proprietary) Limited

Ethnor del Istmo S.A.

Ethnor Farmaceutica, S.A.

Ethnor Guatemala, Sociedad Anomina

Finsbury (Development) Limited

Finsbury (Instruments) Limited

Finsbury Medical Limited

Finsbury Orthopaedics International Limited

Finsbury Orthopaedics Limited

FMS Future Medical System SA

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 18 of 27 PageID #:27521
GH Biotech Holdings Limited

Global Investment Participation B.V.

GMED Healthcare BV

Guangzhou Bioseal Biotech Co., Ltd.

Hansen Medical Deutschland GmbH

Hansen Medical International, Inc.

Hansen Medical UK Limited

Hansen Medical, Inc.

Healthcare Services (Shanghai) Ltd.

I.D. Acquisition Corp.

Innomedic Gesellschaft für innovative Medizintechnik und Informatik 

mbH

Innovalens B.V.

Innovative Surgical Solutions, LLC

J & J Company West Africa Limited

J&J Pension Trustees Limited

J.C. General Services BV

Janssen Alzheimer Immunotherapy (Holding) Limited

Janssen Biologics (Ireland) Limited

Janssen Biologics B.V.

Janssen BioPharma, Inc.

Janssen Biotech, Inc.

Janssen Cilag Farmaceutica S.A.

Janssen Cilag S.p.A.

Janssen Cilag SPA

Janssen Cilag, C.A.

Janssen de Mexico, S. de R.L. de C.V.

Janssen Development Finance Unlimited Company

Janssen Diagnostics, LLC

Janssen Egypt LLC

Janssen Farmaceutica Portugal Lda

Janssen Global Services, LLC

Janssen Group Holdings Limited

Janssen Holding GmbH

Janssen Inc.

Janssen Irish Finance Company UC

Janssen Korea Ltd.

Janssen Oncology, Inc.

Janssen Ortho LLC

Janssen Pharmaceutica (Proprietary) Limited

Janssen Pharmaceutica NV

Janssen Pharmaceutica S.A.

Janssen Pharmaceutical

Janssen Pharmaceutical K.K.

Janssen Pharmaceutical Sciences Unlimited Company

Janssen Pharmaceuticals, Inc.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 19 of 27 PageID #:27522
Janssen Products, LP

Janssen R&D Ireland

Janssen Research & Development, LLC

Janssen Sciences Ireland Unlimited Company

Janssen Scientific Affairs, LLC

Janssen Supply Group, LLC

Janssen Vaccines & Prevention B.V.

Janssen Vaccines Corp.

Janssen-Cilag

Janssen-Cilag (New Zealand) Limited

Janssen-Cilag A/S

Janssen-Cilag AG

Janssen-Cilag Aktiebolag

Janssen-Cilag AS

Janssen-Cilag B.V.

Janssen-Cilag de Mexico S. de R.L. de C.V.

Janssen-Cilag Farmaceutica Lda.

Janssen-Cilag Farmaceutica Ltda.

Janssen-Cilag GmbH

Janssen-Cilag International NV

Janssen-Cilag Kft.

Janssen-Cilag Limited

Janssen-Cilag Limited

Janssen-Cilag Manufacturing, LLC

Janssen-Cilag NV

Janssen-Cilag OY

Janssen-Cilag Pharma GmbH

Janssen-Cilag Pharmaceutical S.A.C.I.

Janssen-Cilag Polska, Sp. z o.o.

Janssen-Cilag Pty Ltd

Janssen-Cilag S.A.

Janssen-Cilag s.r.o.

Janssen-Cilag, S.A.

Janssen-Cilag, S.A. de C.V.

Janssen-Pharma, S.L.

J-C Health Care Ltd.

Jevco Holding, Inc.

JJ Surgical Vision Spain, S.L.

JJC Acquisition Company B.V.

JJHC, LLC

JJSV Belgium BV

JJSV Manufacturing Malaysia SDN. BHD.

JJSV Norden AB

JJSV Produtos Oticos Ltda.

JNJ Global Business Services s.r.o.

JNJ Holding EMEA B.V.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 20 of 27 PageID #:27523
JNJ International Investment LLC

JNJ Irish Investments ULC

Johnson & Johnson

Johnson & Johnson - Societa' Per Azioni

Johnson & Johnson (Angola), Limitada

Johnson & Johnson (China) Investment Ltd.

Johnson & Johnson (Egypt) S.A.E.

Johnson & Johnson (Hong Kong) Limited

Johnson & Johnson (Ireland) Limited

Johnson & Johnson (Jamaica) Limited

Johnson & Johnson (Kenya) Limited

Johnson & Johnson (Middle East) Inc.

Johnson & Johnson (Mozambique), Limitada

Johnson & Johnson (Namibia) (Proprietary) Limited

Johnson & Johnson (New Zealand) Limited

Johnson & Johnson (Philippines), Inc.

Johnson & Johnson (Private) Limited

Johnson & Johnson (Thailand) Ltd.

Johnson & Johnson (Trinidad) Limited

Johnson & Johnson (Vietnam) Co., Ltd

Johnson & Johnson AB

Johnson & Johnson AG

Johnson & Johnson Belgium Finance Company BV

Johnson & Johnson Bulgaria EOOD

Johnson & Johnson China Ltd.

Johnson & Johnson Consumer (Hong Kong) Limited

Johnson & Johnson Consumer (Thailand) Limited

Johnson & Johnson Consumer B.V.

Johnson & Johnson Consumer Holdings France

Johnson & Johnson Consumer Inc.

Johnson & Johnson Consumer NV

Johnson & Johnson Consumer Saudi Arabia Limited

Johnson & Johnson Consumer Services EAME Ltd.

Johnson & Johnson d.o.o.

Johnson & Johnson de Argentina S.A.C. e. I.

Johnson & Johnson de Chile Limitada

Johnson & Johnson de Chile S.A.

Johnson & Johnson de Colombia S.A.

Johnson & Johnson de Costa Rica, S.A.

Johnson & Johnson de Mexico, S.A. de C.V.

Johnson & Johnson de Uruguay S.A.

Johnson & Johnson de Venezuela, S.A.

Johnson & Johnson del Ecuador, S.A.

Johnson & Johnson Del Paraguay, S.A.

Johnson & Johnson del Peru S.A.

Johnson & Johnson do Brasil Industria E Comercio de Produtos Para 

Saude Ltda.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 21 of 27 PageID #:27524
Johnson & Johnson Dominicana, S.A.S.

Johnson & Johnson Enterprise Innovation Inc.

Johnson & Johnson European Treasury Company

Johnson & Johnson Finance Corporation

Johnson & Johnson Finance Limited

Johnson & Johnson Financial Services GmbH

Johnson & Johnson for Export and Import LLC

Johnson & Johnson Foundation Scotland (NON-PROFIT)

Johnson & Johnson Gateway, LLC

Johnson & Johnson Gesellschaft m.b.H.

Johnson & Johnson GmbH

Johnson & Johnson Guatemala, S.A.

Johnson & Johnson Health and Wellness Solutions, Inc.

Johnson & Johnson Health Care Systems Inc.

Johnson & Johnson Hellas Commercial and Industrial S.A.

Johnson & Johnson Hellas Consumer Products Commercial Societe 

Anonyme

Johnson & Johnson Hemisferica S.A.

Johnson & Johnson Holding GmbH

Johnson & Johnson Holdings K.K.

Johnson & Johnson Inc.

Johnson & Johnson Industrial Ltda.

Johnson & Johnson Innovation - JJDC, Inc.

Johnson & Johnson Innovation Limited

Johnson & Johnson Innovation LLC

Johnson & Johnson International

Johnson & Johnson International (Singapore) Pte. Ltd.

Johnson & Johnson International Financial Services Company

Johnson & Johnson Japan Inc.

Johnson & Johnson K.K.

Johnson & Johnson Kft.

Johnson & Johnson Korea Ltd.

Johnson & Johnson Korea Selling & Distribution LLC

Johnson & Johnson Limitada

Johnson & Johnson Limited

Johnson & Johnson LLC

Johnson & Johnson Luxembourg Finance Company Sarl

Johnson & Johnson Management Limited

Johnson & Johnson Medical (China) Ltd.

Johnson & Johnson Medical (Proprietary) Ltd

Johnson & Johnson Medical (Shanghai) Ltd.

Johnson & Johnson Medical (Suzhou) Ltd.

Johnson & Johnson Medical B.V.

Johnson & Johnson Medical Devices & Diagnostics Group - Latin 

America, L.L.C.

Johnson & Johnson Medical GmbH

Johnson & Johnson Medical Korea Ltd.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 22 of 27 PageID #:27525
Johnson & Johnson Medical Limited

Johnson & Johnson Medical Mexico, S.A. de C.V.

Johnson & Johnson Medical NV

Johnson & Johnson Medical Products GmbH

Johnson & Johnson Medical Pty Ltd

Johnson & Johnson Medical S.A.

Johnson & Johnson Medical S.p.A.

Johnson & Johnson Medical SAS

Johnson & Johnson Medical Saudi Arabia Limited

Johnson & Johnson Medical Servicios Profesionales S. de R.L. de C.V.

Johnson & Johnson Medical Taiwan Ltd.

Johnson & Johnson Medical, S.C.S.

Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi

Johnson & Johnson Middle East FZ-LLC

Johnson & Johnson Morocco Societe Anonyme

Johnson & Johnson Nordic AB

Johnson & Johnson Pacific Pty Limited

Johnson & Johnson Pakistan (Private) Limited

Johnson & Johnson Panama, S.A.

Johnson & Johnson Personal Care (Chile) S.A.

Johnson & Johnson Poland Sp. z o.o.

Johnson & Johnson Private Limited

Johnson & Johnson Pte. Ltd.

Johnson & Johnson Pty. Limited

Johnson & Johnson Research Pty Ltd

Johnson & Johnson Romania S.R.L.

Johnson & Johnson S.E. d.o.o.

Johnson & Johnson S.E., Inc.

Johnson & Johnson Sante Beaute France

Johnson & Johnson SDN. BHD.

Johnson & Johnson Services, Inc.

Johnson & Johnson Servicios Corporativos, S. de R.L. de C.V.

Johnson & Johnson Surgical Vision India Private Limited

Johnson & Johnson Surgical Vision, Inc.

Johnson & Johnson Taiwan Ltd.

Johnson & Johnson UK Treasury Company Limited

Johnson & Johnson Ukraine LLC

Johnson & Johnson Urban Renewal Associates

Johnson & Johnson Vision Care (Shanghai) Ltd.

Johnson & Johnson Vision Care Ireland Unlimited Company

Johnson & Johnson Vision Care, Inc.

Johnson & Johnson, S.A.

Johnson & Johnson, S.A. de C.V.

Johnson & Johnson, s.r.o.

Johnson & Johnson, s.r.o.

Johnson and Johnson (Proprietary) Limited

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 23 of 27 PageID #:27526
Johnson and Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi

JOM Pharmaceutical Services, Inc.

La Concha Land Investment Corporation

Latam International Investment Company Unlimited Company

Lifescan

McNeil AB

McNeil Consumer Pharmaceuticals Co.

McNeil Denmark ApS

McNeil Healthcare (Ireland) Limited

McNeil Healthcare (UK) Limited

McNeil Healthcare LLC

McNeil Iberica S.L.U.

McNeil LA LLC

McNEIL MMP, LLC

McNeil Nutritionals, LLC

McNeil Panama, LLC

McNeil Products Limited

McNeil Sweden AB

MDS Co. Ltd.

Medical Device Business Services, Inc.

Medical Devices & Diagnostics Global Services, LLC

Medical Devices International LLC

Medical Industrial do Brasil Ltda.

Medos International Sarl

Medos Sarl

MegaDyne Medical Products, Inc.

Menlo Care De Mexico, S.A. de C.V.

Mentor B.V.

Mentor Deutschland GmbH

Mentor Medical Systems B.V.

Mentor Partnership Holding Company I, LLC

Mentor Texas GP LLC

Mentor Texas L.P.

Mentor Worldwide LLC

Micrus Endovascular LLC

Middlesex Assurance Company Limited

Momenta Ireland Limited

Momenta Pharmaceuticals, Inc.

NeoStrata Company, Inc.

NeoStrata UG (haftungsbeschränkt)

Netherlands Holding Company

Neuravi Inc.

Neuravi Limited

NeuWave Medical, Inc.

Novira Therapeutics, LLC

NuVera Medical, Inc.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 24 of 27 PageID #:27527
Obtech Medical Mexico, S.A. de C.V.

OBTECH Medical Sarl

OGX Beauty AU Pty Ltd

OGX Beauty Limited

OMJ Holding GmbH

OMJ Ireland Unlimited Company

OMJ Pharmaceuticals, Inc.

Omrix Biopharmaceuticals Ltd.

Omrix Biopharmaceuticals NV

Omrix Biopharmaceuticals, Inc.

Ortho Biologics LLC

Ortho Biotech Holding LLC

Ortho-McNeil Pharmaceutical, LLC

Orthotaxy

Patriot Pharmaceuticals, LLC

Peninsula Pharmaceuticals, LLC

Penta Pty. Limited

Percivia LLC

Perouse Plastie

Pharmadirect Ltd.

Pharmedica Laboratories (Proprietary) Limited

PMC Holdings G.K.

Princeton Laboratories, Inc.

Productos de Cuidado Personal y de La Salud de Bolivia S.R.L.

Proleader S.A.

PT Integrated Healthcare Indonesia

PT. Johnson & Johnson Indonesia

Pulsar Vascular, Inc.

Regency Urban Renewal Associates

RespiVert Ltd.

RoC International

Rutan Realty LLC

Scios LLC

Sedona Enterprise Co., Ltd.

Sedona Singapore International Pte. Ltd.

Sedona Thai International Co., Ltd.

Serhum S.A. de C.V.

Shanghai Elsker For Mother & Baby Co., Ltd

Shanghai Johnson & Johnson Ltd.

Shanghai Johnson & Johnson Pharmaceuticals Ltd.

Sightbox, LLC

Sodiac ESV

Spectrum Vision Limited Liability Company

Spectrum Vision Limited Liability Company

Spectrum Vision Limited Liability Partnership

Spine Solutions GmbH

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 25 of 27 PageID #:27528
SterilMed, Inc.

Sterilmed, Inc.

Surgical Process Institute Deutschland GmbH

Synthes Costa Rica S.C.R., Limitada

SYNTHES GmbH

Synthes GmbH

Synthes Holding AG

Synthes Holding Limited

SYNTHES Medical Immobilien GmbH

Synthes Medical Surgical Equipment & Instruments Trading LLC

Synthes Produktions GmbH

Synthes Proprietary Limited

Synthes S.M.P., S. de R.L. de C.V.

Synthes Tuttlingen GmbH

Synthes USA Products, LLC

Synthes USA, LLC

Synthes, Inc.

TARIS Biomedical LLC

TearScience, Inc.

The Anspach Effort, LLC

The Vision Care Institute, LLC

Tibotec, LLC

Torax Medical, Inc.

TriStrata, Incorporated

UAB "Johnson & Johnson"

Vania Expansion

Verb Surgical Inc.

Vision Care Finance Unlimited Company

Vogue International LLC

Vogue International Trading, Inc.

WH4110 Development Company, L.L.C.

Xian Janssen Pharmaceutical Ltd.

XO1 Limited

Zarbee's, Inc.

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 26 of 27 PageID #:27529
CERTIFICATE OF SERVICE 

 I hereby certify that on February 3, 2021, I caused the foregoing to be served on all 

counsel of record via the Court’s ECF system as well as by serving the documents via electronic 

mail upon the following: 

Mudassar Shah (pro se) 

m.shah@esutures.com

mudassarshah79@yahoo.com

/s/ Matthew Morrissey 

 

Case: 1:20-cv-03471 Document #: 370 Filed: 02/03/21 Page 27 of 27 PageID #:27530